1. Home
  2. OCUL vs RSI Comparison

OCUL vs RSI Comparison

Compare OCUL & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • RSI
  • Stock Information
  • Founded
  • OCUL 2006
  • RSI 2012
  • Country
  • OCUL United States
  • RSI United States
  • Employees
  • OCUL N/A
  • RSI N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • RSI Services-Misc. Amusement & Recreation
  • Sector
  • OCUL Health Care
  • RSI Consumer Discretionary
  • Exchange
  • OCUL Nasdaq
  • RSI Nasdaq
  • Market Cap
  • OCUL 957.3M
  • RSI 1.1B
  • IPO Year
  • OCUL 2014
  • RSI N/A
  • Fundamental
  • Price
  • OCUL $8.01
  • RSI $12.70
  • Analyst Decision
  • OCUL Strong Buy
  • RSI Strong Buy
  • Analyst Count
  • OCUL 10
  • RSI 9
  • Target Price
  • OCUL $16.11
  • RSI $15.63
  • AVG Volume (30 Days)
  • OCUL 1.8M
  • RSI 1.2M
  • Earning Date
  • OCUL 05-05-2025
  • RSI 07-30-2025
  • Dividend Yield
  • OCUL N/A
  • RSI N/A
  • EPS Growth
  • OCUL N/A
  • RSI N/A
  • EPS
  • OCUL N/A
  • RSI 0.10
  • Revenue
  • OCUL $59,647,000.00
  • RSI $969,062,000.00
  • Revenue This Year
  • OCUL N/A
  • RSI $16.22
  • Revenue Next Year
  • OCUL $13.38
  • RSI $13.41
  • P/E Ratio
  • OCUL N/A
  • RSI $129.76
  • Revenue Growth
  • OCUL N/A
  • RSI 29.86
  • 52 Week Low
  • OCUL $4.79
  • RSI $8.52
  • 52 Week High
  • OCUL $11.78
  • RSI $16.78
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 56.55
  • RSI 59.75
  • Support Level
  • OCUL $6.86
  • RSI $11.76
  • Resistance Level
  • OCUL $8.21
  • RSI $13.09
  • Average True Range (ATR)
  • OCUL 0.48
  • RSI 0.48
  • MACD
  • OCUL 0.08
  • RSI 0.06
  • Stochastic Oscillator
  • OCUL 86.84
  • RSI 75.16

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About RSI Rush Street Interactive Inc.

Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.

Share on Social Networks: